Estie Mermelstein, MSN, FNP-BC

Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also earned a Bachelor of Arts in journalism and was editor-in-chief of her undergraduate newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have three young children and live in New Jersey.

All articles by Estie Mermelstein, MSN, FNP-BC

Psoriasis Information Center

Adalimumab Plus Methotrexate Promising for Chronic Plaque Psoriasis

Estie Mermelstein, MSN, FNP-BC

September 27, 2022

The efficacy, safety, pharmacokinetics, and immunogenicity of adalimumab combined with MTX compared with that adalimumab in patients with chronic plaque psoriasis is evaluated.

Psoriasis Information Center

Rate of Skin Clearance Linked to Quality of Life in Children With Psoriasis

Estie Mermelstein, MSN, FNP-BC

February 10, 2022

Improvement in psoriasis clearance and its effect on pediatric patients’ quality of life is reviewed.

HIV/AIDS Information Center

Associations Found Between HIV Infection and Impaired Pulmonary Gas Exchange

Estie Mermelstein, MSN, FNP-BC

November 1, 2021

Investigators assessed the relationship between HIV infection and impaired pulmonary gas exchange, as well as the influence HIV has on the diffusing capacity of the lungs for carbon monoxide in patients with and without comorbid chronic obstructive pulmonary disease.

Infectious Diseases Information Center

COVID-19 Vaccine Side Effects Less Common in Real-World vs Phase 3 Trials

Estie Mermelstein, MSN, FNP-BC

September 8, 2021

Investigators compared adverse effects of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines reported in the COVID Symptom Study App with those reported during phase 3 trials.

Infectious Diseases Information Center

Outcomes of COVID-19 in Patients With and Without HIV infection

Estie Mermelstein, MSN, FNP-BC

August 30, 2021

Investigators conducted a retrospective cohort study to determine the difference in COVID-19 outcomes in patients with HIV infection compared with those without HIV infection.

Hepatology Information Center

Opioid Agonist Therapy Linked to Increased HCV Treatment Rates in People Who Inject Drugs

Estie Mermelstein, MSN, FNP-BC

August 12, 2021

Researchers studied the impact of current opioid agonist therapy on initiation of chronic hepatitis C virus treatment among a population of individuals who inject drugs.

Infectious Diseases Information Center

RSV and Parainfluenza Increase Hospitalization Risk in HIV-Exposed Infants

Estie Mermelstein, MSN, FNP-BC

August 5, 2021

As HIV-exposed, uninfected infants have higher rates of morbidity and mortality than HIV-unexposed uninfected infants, a study was conducted to analyze whether particular infections or immune responses contribute to hospitalization.